|
Orexins/Hyporcretins &
Orexins Receptors Antibodies
Several peptides associated with feeding behavior have been reported
recently. Orexins (Orexin-A and Orexin-B) are a
family of hypothalamic neuropeptides selectively expressed in the
hypothalamus (1). Orexin-A and Orexin-B are derived from the same precursor
(Prepro-orexin) by proteolytic cleavage. Prepro-orexin
is 130 amino acid long peptide with a putative 33 AA secretory sequence, a
hydrophobic core followed by residues with small polar side chains. Orexins
are also described as hypocretins.
The mature Orexin-A is a 33-aa peptide (mol. Wt. 3562 Da), with an
N-terminal pyrogutalmyl residue and C-terminal amide. It has 2 disulfide
bonds: Cys6-12 and Cys7-14. Human, bovine, mouse, and rat Orexin-A are
identical. Orexin-B is a 28 AA polypeptide with C-terminal amide (mol. Wt
2937). Orexin-B shares 46% identity with Orexin-A (13/28 AA). Orexin
expression was detected in brain and to a small extent in testis (1). These
neuropeptides bind and activate two closely related Orexin
receptors--G-protein coupled receptors (GPCRs) OX1R
(rat 416 AA, Human 425 aa)
and OX2R
(rat 460 aa; human 444 aa). Northern blots reveal OX1R and OX2R expression
exclusively in the brain (1).
Orexin-A <EPL PDC* C*RQ KTC* SC*R LYE LLH GAG NHA AGI LTL-Amide; 33 AA
(Cys6-Cys-12; Cys7-Cys14); <E=Pyroglutamyl residue.
.
...h Orexins-B, RSG PPG LQG RLQ RLL QAS
GNH AAG ILT M-Amide; 28 aa
m/r Orexins-B, . RPG PPG LQG RLQ RLL QAN
GNH AAG ILT M-Amide; 28 aa
Orexin expression was detected in brain and to a small extent in testis (1).
These neuropeptides bind and activate two closely related Orexin
receptors--G-protein coupled receptors (GPCRs) OX1R and OX2R. Northern blots
reveal OX1R and OX2R expression exclusively in the brain (1).
ADI has produced anti pre-pro-orexin, Orexin-A & B and Orexin receptor
antibodies using a specific peptide sequences. The control peptides were
used to affinity purify the antibodies. The appropriate control immunogenic
peptides are also available to confirm specificity of antibodies.
Availability of these immuno-reagents will contribute to the understanding
of feeding behavior and help cure obesity related diseases.
|
Items |
Antigen
peptide location |
Ab
Host |
Expected
Ab Crossreactivity |
Antisera
Cat #
(100 ul) |
Aff.
Pure IgG
Ab Cat #
(100µl) |
* Control
Peptide Cat#
(100 ug) |
|
Orexin-A |
R/H, 17aa, ~NT |
Rb |
M,R, H,B |
OXA11-S |
OXA11-A |
OXA11-P |
|
Orexin-A
|
OX-A, Human
|
m, mono
|
H, M, R
|
|
OXA15-M
|
|
|
Orexin-B |
R, 13 aa, ~CT |
Rb |
M, R, H |
OXB11-S |
OXB11-A |
OXB11-P |
|
Orexin-B
|
OX-B, Human |
m, mono
|
M, R,
H |
|
OXB15-M
|
|
|
Pre-Pro
Orexin |
R, 17 aa, ~CT |
Rb |
M, R, H |
PPOX11-S |
PPOX11-A |
PPOX11-P |
|
Orexin-1
Receptor |
R/H, 15 aa,
N/C |
Rb |
M, R, H |
OX1R11-S |
OX1R11-A |
OX1R11-P |
|
Orexin-2
Receptor |
R, 19 aa,
N/C |
Rb |
M, R |
OX2R21-S |
OX2R21-A |
OX2R21-P |
|
Orexin-2 Receptor
|
H
|
Rb
|
H
|
OX2R22-S
|
OX2R22-A
|
OX2R22-P
|
|
Orexin-A |
1-33
aa full length |
|
H, M,
R |
|
|
**OXA12-P |
|
Orexin-A |
1-18
aa |
|
H,
M, R |
|
|
**OXA13-P |
|
Orexin-A |
14-33 aa |
|
H, M, R |
|
|
**OXA14-P |
|
Orexin-B |
28 aa, full length |
|
M, R |
|
|
**OXB12-P |
|
Orexin-B |
14-28 aa |
|
M, R |
|
|
**OXB13-P |
|
Orexin-B |
1-28 aa,
Full length |
|
H |
|
|
**OXB14-P |
|
Control
Mouse IgG (non
immune)
|
Control IgG
(-Ve) For ELISA, Western, IHC
|
20008-1 (1 mg) |
|
Control
Rabbit IgG
(non immune) |
Control IgG (-Ve) For ELISA, Western,
IHC
|
20009-1
(1 mg)
|
M= Mouse; R=Rat; H=Human; Ha=Hamster; Rb=Rabbit;
B=Bovine; ; CT= near C-terminus; NT=near
N-terminus; EC=Extracellular
domain; CP
(Cytoplasmic domain)
** Human and Mouse
Orexin-A & B available in 1 mg, 10 mg,
50 mg, 100 mg sizes.
** Expected antibody
crossreactivity information is
mostly based upon high (>70%) sequence
conservation of antigenic/control
peptides in various species. When
antibody crossreactivity has actually
been experimentally confirmed in various
species, it will be mentioned in the
appropriate data sheets.
"Neat Antisera"
are the unpurified antiserum and it is
suitable for ELISA and Western.
"Affinity pure"
IgG may be more suitable for
immunohistochemical (IHC) applications
and to reduce background in most
immunological applications including
ELISA and Western.
"Control
peptides" can not be used for
Western as they are very short peptides.
They are intended for ELISA or antibody
blocking studies to establish antibody
specificity.
All Products
are for in vitro research use only.
40512A

Citations of ADI's Antibodies to Orexins
and Orexin receptors &b Biological
effects of ADI's Orexins
Anti-OX1R
Irving EA et al, Increased cortical
expression of the orexin-1 receptor
following permanent middle cerebral
artery occlusion in the rat (2002)
Neuroscience Lett. in press
WB, IHC (rat brain,
4% PF)
Naslun E
et al, (2002), Localization and effects
of orexin on fasting motility in the rat
duodenum, Am J Physiol Gastrointest
Liver Physiol 282:
G470-G479,
IHC (rat duodenum)
Montserrat Blanco, Miguel López, Tomás
GarcÍa-Caballero, RosalÍa Gallego, Ángel
Vázquez-Boquete, Gerard Morel, Rosa
SeñarÍs, Felipe Casanueva, Carlos
Diéguez, and Andrés Beiras (2001)
Cellular Localization of Orexin
Receptors in Human Pituitary, J. Clin.
Endocrinol. Metab. 86: 3444-3447,
IHC
S. Bingham, a, P. T. Daveya, A. J.
Babbsa, E. A. Irvinga, M. J. Sammonsa,
M. Wylesa, P. Jeffreyb, L. Cutlerb, I.
Ribab, A. Johnsc, R. A. Porterc, N.
Uptona, A. J. Huntera and A. A. Parsons
(2001) Orexin-A, an hypothalamic peptide
with analgesic properties, Pain 2,
81-90, IHC (PF-fixed,
slide mounted and free floating)
Kirchgessner, Kirchgessner (1999) Orexin
Synthesis and Response in the Gut Neuron
24: 941-951, IHC
Blanco M
et al (2001) Cellular Localization of
orexin receptors in human pituitary, J
Clin. Endocrinol. Metabol. 86,
1616-1619, IHC (antigen
retrieval by pressure cooking)
Lopez M
et al (1999) Orexin receptors are
expressed in the adrenal medulla of the
rat Endocrinol. 140, 5991-5994,
IHC
Montserrat Blancoa, Tomás
García-Caballeroa, Máximo Fragab,
Rosalía Gallegoa, Juan Cuevasa, Jerónimo
Fortezab, Andrés Beirasa and Carlos
Diéguez (2001) Cellular localization of
orexin receptors in human adrenal gland,
adrenocortical adenomas and
pheochromocytomas, Regulaotry Peptide
2001 in press, IHC
(formaldehyde,
paraffin embedded sections)'
Naslun E
et al 2002 Localization and effects of
orexin on fasting motility in the rat
duodenum Am J Physiol Gastrointest Liver
Physiol 282: G470-G479,
IHC (rat duodenum)
Anti-OX2R
Lopez M et al 1999 Orexin receptors are
expressed in the adrenal medulla of the
rat Endocrinol. 140, 5991-5994,
IHC
Blanco M et al 2001 Cellular
Localization of orexin receptors in
human pituitary J Clin. Endocrinol.
Metabol. 86, 1616-1619,
IHC (antigen
retrieval by pressure cooking)
Montserrat Blanco, Miguel López, Tomás
GarcÍa-Caballero, RosalÍa Gallego, Ángel
Vázquez-Boquete, Gerard Morel, Rosa
SeñarÍs, Felipe Casanueva, Carlos
Diéguez, and Andrés Beiras 2001 Cellular
Localization of Orexin Receptors in
Human Pituitary J. Clin. Endocrinol.
Metab. 2001 86: 3444-3447,
IHC
Montserrat Blancoa, Tomás
García-Caballeroa, , , Máximo Fragab,
Rosalía Gallegoa, Juan Cuevasa, Jerónimo
Fortezab, Andrés Beirasa and Carlos
Diéguez 2001, Cellular localization of
orexin receptors in human adrenal gland,
adrenocortical adenomas and
pheochromocytomas, Regulaotry Peptide
2001 in press, IHC
(formaldehyde, paraffin)
Kirchgessner, Kirchgessner 1999 Orexin
Synthesis and Response in the Gut Neuron
24: 941-951, IHC
Orexins-A and Orexins-B
OX-A
Dube MG 2000 Evidence of NPY Y5 receptor
involvement in food intake elicited by
orexin A in sated rats Peptides, 21,
1557-1560, ADI's
Orexin-A, Feeding,
biological effect
Dube MG 1999 Food intake elicited by
central administration of orexins/hypocretins:identificaiton
of hypothalamus sites of actions Brain
Res. 842, 473-477,
ADI's Orexin-A feeding biological effect
Jain, Mukul R 2000 Evidence that NPY Y1
receptors are involved in stimulation of
feeding by orexins sated rats Regulatory
Peptides, 87, 19-24,
ADI's Orexin-A
feeding biological effect
Anti Orexin-A
Kirchgessner, Kirchgessner 1999 Orexin
Synthesis and Response in the Gut Neuron
24: 941-951, IHC
Stomach and Intestine
Naslun E et al 2002 Localization and
effects of orexin on fasting motility in
the rat duodenum Am J Physiol
Gastrointest Liver Physiol 282:
G470-G479, IHC
(rat duodenum)
Zbigniew
K Krowicki, Melissa A Burmeister,
Hans-Rudolf Berthoud, Roisin T Scullion,
Kristine Fuchs, and Pamela J Hornby 2002
OREXINS IN RAT DORSAL MOTOR NUCLEUS OF
THE VAGUS POTENTLY STIMULATE GASTRIC
MOTOR FUNCTION Am J Physiol Cell Physiol
2001 in press, IHC
rat brain
Bingham S
et al 2001 Orexin-A, an hypothalamic
peptide with analgesic properties Pain,
2, 81-90, IHC
Zbigniew K Krowicki, Melissa A
Burmeister, Hans-Rudolf Berthoud, Roisin
T Scullion, Kristine Fuchs, and Pamela J
Hornby 2002 OREXINS IN RAT DORSAL MOTOR
NUCLEUS OF THE VAGUS POTENTLY STIMULATE
GASTRIC MOTOR FUNCTION Am J Physiol Cell
Physiol 2001 in press,
IHC rat brain
OX-B
Jain, Mukul R 2000 Evidence that NPY Y1
receptors are involved in stimulation of
feeding by orexins sated rats Regulatory
Peptides, 87, 19-24,
ADI's Orexin-B
Biological effects
Anti-Orexin-B
Kirchgessner, Kirchgessner
1999 Orexin Synthesis and Response in
the Gut Neuron 24: 941-951,
IHC, stomach and
intestine
|